e-Therapeutics is a systems biology drug discovery company. We are industrialising discovery using computers to predict the effects of intervention on proteins in cells. New drugs are identified systematically and very quickly.  

e-Therapeutics uses these capabilities to:

• search for new drugs across several therapeutic areas
• search for new clinical uses for existing drugs
• identify the probability of drug-drug interactions and toxicity

The company’s current portfolio is in anti-infectives, cancer, central nervous system and asthma.

e-Therapeutics also provides consultancy services to pharmaceutical and biotechnology companies analysing drug compounds for indication, efficacy and toxicity.